#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant glioma Hairy cell leukaemia recurrent Scleroderma associated digital ulcer Hereditary motor and sensory neuropathy Infantile spasms Paraneoplastic neurological syndrome Hodgkin's disease Acute respiratory distress syndrome Leber's congenital amaurosis CDKL5 deficiency disorder Herpes simplex Autoimmune demyelinating disease Leukoencephalopathy Leiomyosarcoma recurrent Adrenocortical carcinoma More trials…

    Learn about Rare Diseases

    Urea cycle disorder – Diagnostics Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment Mitochondrial myopathy – Treatment Waldenstrom’s macroglobulinaemia recurrent – Treatment Pulmonary sarcoidosis Rosai-Dorfman syndrome – Life with Disease Congenital nephrogenic diabetes insipidus – Life with Disease Marginal zone lymphoma refractory – Basic Information Marfan’s syndrome – Diagnostics Toxic epidermal necrolysis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Methionine Obicetrapib Clic-1901 Cart Romidepsin Mitazalimab Mdna11 Dog Epithelia L-Histidine APAZUNERSEN Zimberelimab Aliskiren ALE.P03 Carbamazepine Ferrous Sulfate Ads-010 Treg02 Chlorphenamine Sodium S-Lactate Solution Tacrolimus Fipaxalparant More therapies…

    Learn about Your Condition

    Craniocerebral injury Uveitis Arteriospasm coronary Hip fracture White matter lesion Low cardiac output syndrome Thalassaemia alpha Endometrial cancer recurrent Neurofibromatosis Hepatic angiosarcoma Neuropathy peripheral Hydrocephalus Chronic lymphocytic leukaemia Nasal sinus cancer Viral myocarditis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Early Detection and Treatment of ER Positive HER2 Negative Breast Cancer Using Palbociclib, Fulvestrant, and Drug Combination for Patients with Molecular Relapse

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Tamoxifen Citrate
    • Anastrozole
    • Exemestane
    France

  • Study on Sirolimus and Mycophenolate Mofetil for Reducing Hernia Risk in Type 1 Diabetes Patients with End-Stage Kidney Disease Undergoing Pancreas and Kidney Transplantation

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Sirolimus
    • Mycophenolate Mofetil
    Czechia

  • Study on Neurodegenerative Diseases Using [18F]RO6958948 for Early Detection and Mapping in At-Risk Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neurodegenerative disorder
    Investigated Drugs:
    • 2-(6-[18F]Fluoro-Pyridin-3-Yl)-9H-Dipyrido[2,3-B:3′,4′-D]Pyrrole
    Sweden

  • Study on the Effectiveness and Safety of Ademetionine with Antidepressants for Patients with Major Depressive Disorder

    Recruiting

    3 1 1
    Investigated Drugs:
    • Ademetionine
    Italy

  • Comparison of dapagliflozin and oral semaglutide effectiveness in type 2 diabetes patients based on insulin resistance or secretion deficit

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Insulin Glargine
    • Dapagliflozin
    • Semaglutide
    Italy

  • Study on Post-Neoadjuvant Therapy for Early Breast Cancer Using Ipatasertib, Inavolisib, and Atezolizumab for Patients with High-Risk Early Breast Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Ipatasertib
    • Inavolisib
    • Sacituzumab Govitecan
    Germany
Previous Page
1 … 605 606 607 608 609 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!